0.9% Sodium Chloride NDC 51662-1520

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1520Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1520Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1520-1	51662152001	100 mL in 1 BAG (51662-1520-1)Marketed from May 21, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): 0.9% Sodium Chloride
Generic name (nonproprietary): 0.9% sodium chloride
Active ingredients: Sodium chloride — 900 mg/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 016366
Marketing start: May 21, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
Identifiers: Product ID 51662-1520_a62b71db-8ba3-6f6b-e053-2a95a90a29d1SPL ID a62b71db-8ba3-6f6b-e053-2a95a90a29d1SPL set ID a62b71db-8ba2-6f6b-e053-2a95a90a29d1RxCUI 1807632UNII 451W47IQ8X
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662152001 followed by a unit qualifier and the quantity

Package 51662-1520-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 016366

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 016366
Product	Strength	Form · route	Labeler	Product NDC
0.9% Sodium Chloride	Sodium chloride 900 mg/100mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1518
0.9% Sodium Chloride	Sodium chloride 900 mg/100mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1517
Sodium Chloride	Sodium chloride 900 mg/100mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1522
Sodium Chloride	Sodium chloride 900 mg/100mL	Injection, SolutionIntravenous	ICU Medical Inc.	0990-7983
Sodium Chloride	Sodium chloride 900 mg/100mL	Injection, SolutionIntravenous	ICU Medical Inc.	0990-7984